157 related articles for article (PubMed ID: 16638702)
1. No major effect of the CD28/CTLA4/ICOS gene region on susceptibility to primary sclerosing cholangitis.
Wiencke K; Boberg KM; Donaldson P; Harbo H; Ling V; Schrumpf E; Spurkland A
Scand J Gastroenterol; 2006 May; 41(5):586-91. PubMed ID: 16638702
[TBL] [Abstract][Full Text] [Related]
2. Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients.
Lorentzen AR; Celius EG; Ekstrøm PO; Wiencke K; Lie BA; Myhr KM; Ling V; Thorsby E; Vartdal F; Spurkland A; Harbo HF
J Neuroimmunol; 2005 Sep; 166(1-2):197-201. PubMed ID: 16005527
[TBL] [Abstract][Full Text] [Related]
3. Evidence for unique association signals in SLE at the CD28-CTLA4-ICOS locus in a family-based study.
Cunninghame Graham DS; Wong AK; McHugh NJ; Whittaker JC; Vyse TJ
Hum Mol Genet; 2006 Nov; 15(21):3195-205. PubMed ID: 17000707
[TBL] [Abstract][Full Text] [Related]
4. Genetic analysis of the 2q33 region containing CD28-CTLA4-ICOS genes: association with non-Hodgkin's lymphoma.
Piras G; Monne M; Uras A; Palmas A; Murineddu M; Arru L; Bianchi A; Calvisi A; Curreli L; Gaviano E; Lai P; Murgia A; Latte GC; Noli A; Gabbas A
Br J Haematol; 2005 Jun; 129(6):784-90. PubMed ID: 15953005
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of the CD28/CTLA4/ICOS (CELIAC3) region in coeliac disease.
Amundsen SS; Naluai AT; Ascher H; Ek J; Gudjónsdóttir AH; Wahlström J; Lie BA; Sollid LM
Tissue Antigens; 2004 Nov; 64(5):593-9. PubMed ID: 15496203
[TBL] [Abstract][Full Text] [Related]
6. Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma.
Cheng TY; Lin JT; Chen LT; Shun CT; Wang HP; Lin MT; Wang TE; Cheng AL; Wu MS
J Clin Oncol; 2006 Jul; 24(21):3483-9. PubMed ID: 16849765
[TBL] [Abstract][Full Text] [Related]
7. Haplotypes in the CTLA4 region are associated with coeliac disease in the Irish population.
Brophy K; Ryan AW; Thornton JM; Abuzakouk M; Fitzgerald AP; McLoughlin RM; O'morain C; Kennedy NP; Stevens FM; Feighery C; Kelleher D; McManus R
Genes Immun; 2006 Jan; 7(1):19-26. PubMed ID: 16237465
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in the 2q33 and 3q21 chromosome regions including T-cell coreceptor and ligand genes may influence susceptibility to pemphigus foliaceus.
Dalla-Costa R; Pincerati MR; Beltrame MH; Malheiros D; Petzl-Erler ML
Hum Immunol; 2010 Aug; 71(8):809-17. PubMed ID: 20433886
[TBL] [Abstract][Full Text] [Related]
9. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population.
Suwalska K; Pawlak E; Karabon L; Tomkiewicz A; Dobosz T; Urbaniak-Kujda D; Kuliczkowski K; Wolowiec D; Jedynak A; Frydecka I
Hum Immunol; 2008 Mar; 69(3):193-201. PubMed ID: 18396212
[TBL] [Abstract][Full Text] [Related]
10. Genetic association of coeliac disease susceptibility to polymorphisms in the ICOS gene on chromosome 2q33.
Haimila K; Smedberg T; Mustalahti K; Mäki M; Partanen J; Holopainen P
Genes Immun; 2004 Mar; 5(2):85-92. PubMed ID: 14712308
[TBL] [Abstract][Full Text] [Related]
11. Influence of CTLA4 haplotypes on susceptibility and some extraglandular manifestations in primary Sjögren's syndrome.
Downie-Doyle S; Bayat N; Rischmueller M; Lester S
Arthritis Rheum; 2006 Aug; 54(8):2434-40. PubMed ID: 16869018
[TBL] [Abstract][Full Text] [Related]
12. Assembly and annotation of human chromosome 2q33 sequence containing the CD28, CTLA4, and ICOS gene cluster: analysis by computational, comparative, and microarray approaches.
Ling V; Wu PW; Finnerty HF; Agostino MJ; Graham JR; Chen S; Jussiff JM; Fisk GJ; Miller CP; Collins M
Genomics; 2001 Dec; 78(3):155-68. PubMed ID: 11735222
[TBL] [Abstract][Full Text] [Related]
13. No evidence of association of CTLA4 polymorphisms with Addison's disease.
Pérez de Nanclares G; Martín-Pagola A; Ramón Bilbao J; Vázquez F; Castaño L
Autoimmunity; 2004; 37(6-7):453-6. PubMed ID: 15621571
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in ICOS regulates mRNA levels of ICOS and splicing isoforms of CTLA4.
Kaartinen T; Lappalainen J; Haimila K; Autero M; Partanen J
Mol Immunol; 2007 Mar; 44(7):1644-51. PubMed ID: 16996590
[TBL] [Abstract][Full Text] [Related]
15. Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population.
Pawlak E; Karabon L; Wlodarska-Polinska I; Jedynak A; Jonkisz A; Tomkiewicz A; Kornafel J; Stepien M; Ignatowicz A; Lebioda A; Dobosz T; Frydecka I
Hum Immunol; 2010 Feb; 71(2):195-200. PubMed ID: 19913589
[TBL] [Abstract][Full Text] [Related]
16. Interaction of immunological genes on chromosome 2q33 and IFNG in susceptibility to cervical cancer.
Ivansson EL; Juko-Pecirep I; Gyllensten UB
Gynecol Oncol; 2010 Mar; 116(3):544-8. PubMed ID: 19959217
[TBL] [Abstract][Full Text] [Related]
17. Immunoregulatory gene polymorphisms in women with preeclampsia.
Pendeloski KP; Sass N; Torloni MR; Mattar R; Moron AF; Franchim CS; Daher S
Hypertens Res; 2011 Mar; 34(3):384-8. PubMed ID: 21160481
[TBL] [Abstract][Full Text] [Related]
18. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with type 1 diabetes in the Japanese population.
Ihara K; Ahmed S; Nakao F; Kinukawa N; Kuromaru R; Matsuura N; Iwata I; Nagafuchi S; Kohno H; Miyako K; Hara T
Immunogenetics; 2001 Aug; 53(6):447-54. PubMed ID: 11685455
[TBL] [Abstract][Full Text] [Related]
19. Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes.
Wiencke K; Karlsen TH; Boberg KM; Thorsby E; Schrumpf E; Lie BA; Spurkland A
Tissue Antigens; 2007 Feb; 69(2):161-9. PubMed ID: 17257319
[TBL] [Abstract][Full Text] [Related]
20. Association of genetic variation in co-stimulatory molecule genes with outcome of liver transplant in Iranian patients.
Karimi MH; Motazedian M; Abedi F; Yaghobi R; Geramizadeh B; Nikeghbalian S
Gene; 2012 Aug; 504(1):127-32. PubMed ID: 22579879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
